HERTFORDSHIRE, England and PITTSBURGH, Jan. 31, 2019 /PRNewswire/ -- Mylan N.V. (NASDAQ: MYL) today announced the U.S. Food and Drug Administration (FDA) approval of Wixelaâ„¢ Inhubâ„¢ (fluticasone ...
wixela-product-image Wixela Inhub (fluticasone propionate and salmeterol inhalation powder), the first substitutable generic of Advair Diskus (GlaxoSmithKline), has been made available by Mylan Mylan ...
As with all medications, the cost of Advair can vary. Factors that may affect the price you’ll pay include: your treatment plan the form of Advair you’re prescribed your insurance coverage the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results